-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Expanding from "you buy me to sell" to cooperation, asset portfolio, seller's reserved equity and other forms
Expanding from "you buy me to sell" to cooperation, asset portfolio, seller's reserved equity and other formsRecently, the investment industry, represented by private equity firms, has been increasingly involved in M&A transactions in the chemical industry
Recently, the investment industry, represented by private equity firms, has been increasingly involved in M&A transactions in the chemical industry
Increased flexibility in chemical M&A transactions Increased flexibility in chemical M&A transactions
Federico Mennera, global head of chemicals and materials at investment bank Rothschild, said: “I think that today’s private equity firms and strategic buyers are dealing with relatively straightforward M&A deals compared to most M&A deals in the past.
Rothschild AG advised on the acquisition of DSM's engineered materials division by Germany's Lanxess AG and private equity firm Acron Capital
In January, Switzerland-based Clariant sold its pigments business to pigment producer Huybach Group and private equity firm SK Capital for 805 million Swiss francs
Increased flexibility in M&A transactions can serve multiple purposes
Economic Situation Facilitates Flexible M&A
Economic Situation Promotes Flexible M&A Economic Situation Promotes Flexible M&AThis year, global chemical M&A activity has slowed as a whole, especially in Europe, where geopolitical conflict is prominent, due to rising risks of a global recession, rising interest rates and reduced financing channels
In May, SK Capital agreed to acquire Valtris Specialty Chemicals, a U.
"Private equity firms are playing an increasingly important role in chemical M&A transactions," Menella said
